Interpretation of Incidence Rates Data
Incidence Rate Report by State
Liver & Bile Duct (Late Stage^), 2017-2021
All Races (includes Hispanic), Both Sexes, All Ages
Sorted by Name
Explanation of Column HeadersObjective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.
Other Notes
- Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
- Data is currently being suppressed if there are fewer than 16 counts for the time period.
Line by Line Interpretation of the Report
US (SEER+NPCR)1
- Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.6 to 3.6 and 14,962 average annual cases over 2017-2021.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : 41.7
Wyoming6
- Rate : The incidence rate is 2.1 with a 95% confidence interval from 1.7 to 2.6 and 17 average annual cases over 2017-2021.
- CI*Rank ⋔ : 50 (40, 50)
- Percent of Cases with Late Stage : 41.1
Wisconsin6
- Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.3 and 251 average annual cases over 2017-2021.
- CI*Rank ⋔ : 32 (23, 42)
- Percent of Cases with Late Stage : 43.4
West Virginia6
- Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.0 to 3.7 and 89 average annual cases over 2017-2021.
- CI*Rank ⋔ : 27 (10, 42)
- Percent of Cases with Late Stage : 40.2
Washington5
- Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.8 to 4.2 and 381 average annual cases over 2017-2021.
- CI*Rank ⋔ : 8 (4, 16)
- Percent of Cases with Late Stage : 44.7
Virginia6
- Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.7 to 3.0 and 316 average annual cases over 2017-2021.
- CI*Rank ⋔ : 42 (33, 47)
- Percent of Cases with Late Stage : 39.3
Vermont6
- Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.3 to 3.4 and 27 average annual cases over 2017-2021.
- CI*Rank ⋔ : 44 (17, 50)
- Percent of Cases with Late Stage : 46.0
Utah3
- Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.7 to 3.3 and 90 average annual cases over 2017-2021.
- CI*Rank ⋔ : 37 (23, 47)
- Percent of Cases with Late Stage : 44.8
Texas3
- Rate : The incidence rate is 4.8 with a 95% confidence interval from 4.7 to 4.9 and 1,508 average annual cases over 2017-2021.
- CI*Rank ⋔ : 2 (1, 4)
- Percent of Cases with Late Stage : 38.7
Tennessee6
- Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.2 to 3.6 and 308 average annual cases over 2017-2021.
- CI*Rank ⋔ : 24 (15, 34)
- Percent of Cases with Late Stage : 39.8
South Dakota6
- Rate : The incidence rate is 3.3 with a 95% confidence interval from 2.8 to 3.8 and 38 average annual cases over 2017-2021.
- CI*Rank ⋔ : 29 (6, 48)
- Percent of Cases with Late Stage : 47.0
South Carolina6
- Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.4 and 224 average annual cases over 2017-2021.
- CI*Rank ⋔ : 30 (21, 41)
- Percent of Cases with Late Stage : 39.9
Rhode Island6
- Rate : The incidence rate is 4.4 with a 95% confidence interval from 3.9 to 4.9 and 64 average annual cases over 2017-2021.
- CI*Rank ⋔ : 3 (1, 17)
- Percent of Cases with Late Stage : 50.1
Puerto Rico6
- Rate : The incidence rate is 2.0 with a 95% confidence interval from 1.8 to 2.2 and 92 average annual cases over 2017-2021.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : 25.0
Pennsylvania6
- Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.6 to 3.9 and 686 average annual cases over 2017-2021.
- CI*Rank ⋔ : 14 (7, 20)
- Percent of Cases with Late Stage : 44.3
Oregon6
- Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.8 and 204 average annual cases over 2017-2021.
- CI*Rank ⋔ : 18 (9, 31)
- Percent of Cases with Late Stage : 38.6
Oklahoma6
- Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.1 to 3.6 and 167 average annual cases over 2017-2021.
- CI*Rank ⋔ : 26 (13, 37)
- Percent of Cases with Late Stage : 36.4
Ohio6
- Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.2 and 491 average annual cases over 2017-2021.
- CI*Rank ⋔ : 36 (28, 41)
- Percent of Cases with Late Stage : 40.0
North Dakota6
- Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.4 to 3.5 and 27 average annual cases over 2017-2021.
- CI*Rank ⋔ : 38 (13, 50)
- Percent of Cases with Late Stage : 44.2
North Carolina6
- Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.7 to 4.0 and 525 average annual cases over 2017-2021.
- CI*Rank ⋔ : 9 (5, 17)
- Percent of Cases with Late Stage : 43.2
New York3
- Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.7 to 3.9 and 991 average annual cases over 2017-2021.
- CI*Rank ⋔ : 13 (7, 18)
- Percent of Cases with Late Stage : 45.4
New Mexico3
- Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.6 to 3.2 and 83 average annual cases over 2017-2021.
- CI*Rank ⋔ : 40 (26, 49)
- Percent of Cases with Late Stage : 29.8
New Jersey3
- Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.2 to 3.5 and 407 average annual cases over 2017-2021.
- CI*Rank ⋔ : 25 (16, 32)
- Percent of Cases with Late Stage : 42.5
New Hampshire6
- Rate : The incidence rate is 2.4 with a 95% confidence interval from 2.1 to 2.8 and 48 average annual cases over 2017-2021.
- CI*Rank ⋔ : 49 (39, 50)
- Percent of Cases with Late Stage : 37.7
Nevada6
- Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.3 to 2.8 and 98 average annual cases over 2017-2021.
- CI*Rank ⋔ : 48 (39, 50)
- Percent of Cases with Late Stage : 35.4
Nebraska6
- Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.4 to 3.1 and 66 average annual cases over 2017-2021.
- CI*Rank ⋔ : 45 (31, 50)
- Percent of Cases with Late Stage : 45.6
Montana6
- Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.7 to 3.5 and 49 average annual cases over 2017-2021.
- CI*Rank ⋔ : 34 (14, 48)
- Percent of Cases with Late Stage : 43.9
Missouri6
- Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.5 to 3.9 and 303 average annual cases over 2017-2021.
- CI*Rank ⋔ : 16 (7, 26)
- Percent of Cases with Late Stage : 45.3
Mississippi6
- Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.6 to 4.1 and 150 average annual cases over 2017-2021.
- CI*Rank ⋔ : 11 (4, 24)
- Percent of Cases with Late Stage : 44.0
Minnesota6
- Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.4 and 224 average annual cases over 2017-2021.
- CI*Rank ⋔ : 31 (22, 41)
- Percent of Cases with Late Stage : 39.5
Michigan6
- Rate : The incidence rate is 3.1 with a 95% confidence interval from 3.0 to 3.3 and 436 average annual cases over 2017-2021.
- CI*Rank ⋔ : 33 (26, 40)
- Percent of Cases with Late Stage : 44.1
Maryland6
- Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.7 and 271 average annual cases over 2017-2021.
- CI*Rank ⋔ : 23 (13, 32)
- Percent of Cases with Late Stage : 40.9
Maine6
- Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.4 to 3.0 and 55 average annual cases over 2017-2021.
- CI*Rank ⋔ : 47 (30, 50)
- Percent of Cases with Late Stage : 39.8
Louisiana3
- Rate : The incidence rate is 4.8 with a 95% confidence interval from 4.6 to 5.1 and 294 average annual cases over 2017-2021.
- CI*Rank ⋔ : 1 (1, 4)
- Percent of Cases with Late Stage : 45.8
Kentucky3
- Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.8 to 4.3 and 237 average annual cases over 2017-2021.
- CI*Rank ⋔ : 7 (3, 16)
- Percent of Cases with Late Stage : 45.1
Kansas6
- Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.6 to 3.1 and 105 average annual cases over 2017-2021.
- CI*Rank ⋔ : 41 (29, 49)
- Percent of Cases with Late Stage : 39.4
Iowa3
- Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.2 to 3.8 and 146 average annual cases over 2017-2021.
- CI*Rank ⋔ : 20 (9, 34)
- Percent of Cases with Late Stage : 48.5
Illinois3
- Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.2 to 3.4 and 538 average annual cases over 2017-2021.
- CI*Rank ⋔ : 28 (20, 35)
- Percent of Cases with Late Stage : 40.9
Idaho3
- Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.8 to 3.4 and 70 average annual cases over 2017-2021.
- CI*Rank ⋔ : 35 (17, 47)
- Percent of Cases with Late Stage : 41.8
Hawaii3
- Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.4 to 4.2 and 74 average annual cases over 2017-2021.
- CI*Rank ⋔ : 12 (3, 31)
- Percent of Cases with Late Stage : 39.3
Georgia3
- Rate : The incidence rate is 4.3 with a 95% confidence interval from 4.1 to 4.4 and 536 average annual cases over 2017-2021.
- CI*Rank ⋔ : 4 (3, 8)
- Percent of Cases with Late Stage : 50.9
Florida6
- Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.4 to 3.6 and 1,112 average annual cases over 2017-2021.
- CI*Rank ⋔ : 22 (16, 28)
- Percent of Cases with Late Stage : 41.7
District of Columbia6
- Rate : The incidence rate is 4.2 with a 95% confidence interval from 3.6 to 5.0 and 30 average annual cases over 2017-2021.
- CI*Rank ⋔ : 5 (1, 31)
- Percent of Cases with Late Stage : 36.6
Delaware6
- Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.1 to 4.0 and 50 average annual cases over 2017-2021.
- CI*Rank ⋔ : 21 (5, 41)
- Percent of Cases with Late Stage : 42.9
Connecticut3
- Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.8 and 175 average annual cases over 2017-2021.
- CI*Rank ⋔ : 19 (8, 32)
- Percent of Cases with Late Stage : 45.4
Colorado6
- Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.0 and 192 average annual cases over 2017-2021.
- CI*Rank ⋔ : 43 (33, 48)
- Percent of Cases with Late Stage : 39.1
California3
- Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.8 to 3.9 and 1,794 average annual cases over 2017-2021.
- CI*Rank ⋔ : 10 (6, 16)
- Percent of Cases with Late Stage : 40.1
Arkansas6
- Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.3 to 3.8 and 140 average annual cases over 2017-2021.
- CI*Rank ⋔ : 17 (7, 34)
- Percent of Cases with Late Stage : 43.4
Arizona6
- Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.8 to 3.1 and 273 average annual cases over 2017-2021.
- CI*Rank ⋔ : 39 (31, 47)
- Percent of Cases with Late Stage : 36.7
Alaska6
- Rate : The incidence rate is 4.2 with a 95% confidence interval from 3.6 to 4.9 and 34 average annual cases over 2017-2021.
- CI*Rank ⋔ : 6 (1, 29)
- Percent of Cases with Late Stage : 43.5
Alabama6
- Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.5 to 2.9 and 186 average annual cases over 2017-2021.
- CI*Rank ⋔ : 46 (36, 49)
- Percent of Cases with Late Stage : 32.7
- Rate : Data not available for this combination of data selections.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : data not available
Notes:
Created by statecancerprofiles.cancer.gov on 10/07/2024 2:22 pm.
State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.
^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
Data not available for this combination of data selections.
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
3 Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).
Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.